Creative Financial Designs’s Filana Therapeutics FLNA Stock Holding History

Creative Financial Designs’s Portfolio FLNA Stock Details FLNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$48	Hold	40	–	–	﹤0.01%	2242
2026 Q1	$68	Hold	40	–	–	﹤0.01%	2137
2025 Q4	$79	Hold	40	–	–	﹤0.01%	2035
2025 Q3	$116	Hold	40	–	–	﹤0.01%	2020
2025 Q2	$72	Sell	40 -80	-67%	-$142	﹤0.01%	1990
2025 Q1	$180	Sell	120 -32	-21%	-$81	﹤0.01%	1989
2024 Q4	$359	Hold	152	–	–	﹤0.01%	1745
2024 Q3	$4.47K	Hold	152	–	–	﹤0.01%	1405
2024 Q2	$1.88K	Hold	152	–	–	﹤0.01%	1486
2024 Q1	$3.08K	Buy	152 +12	+9%	+$276	﹤0.01%	1415
2023 Q4	$3.15K	Hold	140	–	–	﹤0.01%	1348
2023 Q3	$2.33K	Hold	140	–	–	﹤0.01%	1320
2023 Q2	$3.43K	Hold	140	–	–	﹤0.01%	1238
2023 Q1	$3.38K	Hold	140	–	–	﹤0.01%	1187
2022 Q4	$4.14K	Hold	140	–	–	﹤0.01%	1072
2022 Q3	$6K	Hold	140	–	–	﹤0.01%	1009
2022 Q2	$4K	Hold	140	–	–	﹤0.01%	1062
2022 Q1	$5K	Buy	140 +130	+1,300%	+$5.51K	﹤0.01%	1052
2021 Q4	$0	Buy	+10	New	+$524	﹤0.01%	1408

Other funds holding FLNA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Creative Financial Designs's FLNA Position: Q2 2026 in Review

Creative Financial Designs held its Filana Therapeutics (FLNA) position steady in Q2 2026 at 40 shares worth $48. The position accounts for ﹤0.01% of the portfolio, ranked #2242.

Creative Financial Designs first reported a position in FLNA in Q4 2021 and has held it in 19 quarters since. The position peaked at $6K in Q3 2022. 85 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

Creative Financial Designs held 40 shares of Filana Therapeutics worth $48 as of Q2 2026.
Creative Financial Designs left its Filana Therapeutics share count unchanged in Q2 2026.
Filana Therapeutics made up ﹤0.01% of Creative Financial Designs's portfolio in Q2 2026, its #2242 holding.
Creative Financial Designs first reported a position in Filana Therapeutics in Q4 2021 and has held it in 19 quarters since.
Creative Financial Designs's Filana Therapeutics position peaked at $6K in Q3 2022.
85 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Creative Financial Designs's 13F filing for Q2 2026, filed 28 Jul 2026.